Home
About
Directory
Promoted Listings
Purchase Data
Drug Pipelines
Data Licensing
Newsletter
Contact
Imugen
is defunct.
Acquired by Oxford Immunotec, Jul 2016, $22M
------------------
If you believe any of this information is incorrect, please
let us know
.